These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
669 related articles for article (PubMed ID: 25085957)
1. Psoriasis. Di Meglio P; Villanova F; Nestle FO Cold Spring Harb Perspect Med; 2014 Aug; 4(8):. PubMed ID: 25085957 [TBL] [Abstract][Full Text] [Related]
2. Emerging therapies in psoriasis: a systematic review. Lee EB; Amin M; Bhutani T; Wu JJ Cutis; 2018 Mar; 101(3S):5-9. PubMed ID: 29718027 [TBL] [Abstract][Full Text] [Related]
3. Potential future therapies for psoriasis. Papp KA Semin Cutan Med Surg; 2005 Mar; 24(1):58-63. PubMed ID: 15900800 [No Abstract] [Full Text] [Related]
4. Psoriasis: disease management with a brief review of new biologics. Khachemoune A; Guillen S Dermatol Nurs; 2006 Feb; 18(1):40-3, 49. PubMed ID: 16550896 [TBL] [Abstract][Full Text] [Related]
5. Switching biological agents for psoriasis in secondary care: a single-centre, retrospective, open-label study. Woo WA; Waite A; Rustin MH; McBride SR Br J Dermatol; 2014 Apr; 170(4):989-90. PubMed ID: 24298875 [No Abstract] [Full Text] [Related]
6. Psoriasis: the future. Menter MA; Griffiths CE Dermatol Clin; 2015 Jan; 33(1):161-6. PubMed ID: 25412790 [TBL] [Abstract][Full Text] [Related]
7. Progress to Date in Advancing Stratified Medicine in Psoriasis. Reid C; Cordingley L; Warren RB; Griffiths CEM Am J Clin Dermatol; 2020 Oct; 21(5):619-626. PubMed ID: 32607944 [TBL] [Abstract][Full Text] [Related]
8. Tattoo sites and psoriasis. Smith SF; Feldman SR J Drugs Dermatol; 2011 Oct; 10(10):1199-200. PubMed ID: 21968672 [TBL] [Abstract][Full Text] [Related]
9. [New therapies in psoriasis]. Ferrándiz C Med Clin (Barc); 2007 Sep; 129(10):377-8. PubMed ID: 17915133 [No Abstract] [Full Text] [Related]
10. Use of biologic agents in combination with other therapies for the treatment of psoriasis. Cather JC; Crowley JJ Am J Clin Dermatol; 2014 Dec; 15(6):467-78. PubMed ID: 25373522 [TBL] [Abstract][Full Text] [Related]
12. Treatment of psoriasis and psoriatic arthritis. Papoutsaki M; Costanzo A BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of sequential biologic therapy with ixekizumab versus secukinumab as first-line treatment of moderate-to-severe psoriasis in the UK. Johansson EC; Hartz S; Kiri SH; Kumar G; Svedbom A J Med Econ; 2018 Aug; 21(8):810-820. PubMed ID: 29873270 [TBL] [Abstract][Full Text] [Related]
17. Small molecules and antibodies for the treatment of psoriasis: a patent review (2010-2015). Chiricozzi A; Saraceno R; Novelli L; Fida M; Caso F; Scarpa R; Costa L; Perricone R; Romanelli M; Chimenti S; Chimenti MS Expert Opin Ther Pat; 2016 Jul; 26(7):757-66. PubMed ID: 27266423 [TBL] [Abstract][Full Text] [Related]
18. [Possibilities and limits for treating psoriasis with biologics. Case reports]. Süss A; Colsman A; Simon JC; Sticherling M Hautarzt; 2009 Jan; 60(1):51-6. PubMed ID: 18712323 [TBL] [Abstract][Full Text] [Related]
19. Antidrug antibodies in psoriasis: a systematic review. Hsu L; Snodgrass BT; Armstrong AW Br J Dermatol; 2014 Feb; 170(2):261-73. PubMed ID: 24117166 [TBL] [Abstract][Full Text] [Related]
20. Genital Psoriasis: Impact on Quality of Life and Treatment Options. Kelly A; Ryan C Am J Clin Dermatol; 2019 Oct; 20(5):639-646. PubMed ID: 31313079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]